What is 1606 Corp's earnings per share (EPS)?

1606 Corp (CBDW) reported diluted earnings per share of $-0.01 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

1606 Corp Financials

CBDW

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows 1606 Corp (CBDW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CBDW FY2025 2026-05-15

The visible mechanic is balance-sheet survival: liabilities keep climbing while liquidity stays near zero.

From FY2023 to FY2025, shares outstanding rose from 58.6M to 472.4M even as cash fell from $48.9K to $0 and liabilities increased from $1.56M to $3.24M, meaning the capital structure changed dramatically without creating a cash buffer.

FY2025 ended with just $16.1K of assets against $3.24M of liabilities, and the current ratio stayed well below 0.1x; that combination implies day-to-day funding depends more on obligations than on internally generated resources.

Some figures from recent filings were inconsistent and were omitted from this summary.

Financial Health Signals

Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of 1606 Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

1606 Corp's revenue declined 100% year-over-year, from $7K to $0. This contraction results in a growth score of 0/100.

Leverage

100

1606 Corp carries a low D/E ratio of -0.64, meaning only $-0.64 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

1606 Corp's current ratio of 0.01 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

YoY-100.0%

1606 Corp generated $0 in revenue in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$-0.01

1606 Corp earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 83.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

YoY-100.0%

1606 Corp held $0 in cash against $2.1M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

472M

1606 Corp had 472M shares outstanding in fiscal year 2025. This represents an increase of 319.1% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

CBDW Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$0-100.0%	$7K+348.8%	$2K-88.5%	$14K-59.1%	$34K-49.8%	$68K
Cost of Revenue	$0-100.0%	$7K+635.0%	$995-92.2%	$13K-41.2%	$22K-58.1%	$52K
Gross Profit	$0+100.0%	-$118-119.4%	$608-48.6%	$1K-90.4%	$12K-23.0%	$16K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	$541K+887.4%	$55K-77.5%	$244K
Operating Income	N/A	N/A	N/A	-$540K	N/A	N/A
Interest Expense	N/A	N/A	-$154K	N/A	N/A	N/A
Income Tax	$0	$0	$0	$0	$0	$0
Net Income	N/A	N/A	N/A	-$540K	N/A	-$228K
EPS (Diluted)	$-0.01	$-0.06-100.0%	$-0.03	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	$0	$0	$0	N/A	$0	$0
Cost of Revenue	N/A	N/A	$0	$0	$0	N/A	$0	$0
Gross Profit	N/A	N/A	$0	$0	$0	N/A	$0	$0
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$168K	N/A	N/A	$117K	N/A	N/A	N/A	$289K
Operating Income	-$168K	N/A	N/A	-$117K	N/A	N/A	N/A	-$289K
Interest Expense	N/A	N/A	N/A	$63K	N/A	N/A	$98K-23.4%	$128K
Income Tax	$0	N/A	$0	$0	$0	N/A	$0	$0
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$339K
EPS (Diluted)	$0.00	N/A	$0.00	$0.00	$0.00	N/A	$-0.07-600.0%	$-0.01

CBDW Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$16K+58.4%	$10K-93.2%	$148K-36.0%	$232K+465.5%	$41K-18.6%	$50K
Current Assets	$16K+58.4%	$10K-93.2%	$148K-36.0%	$232K	N/A	N/A
Cash & Equivalents	$0-100.0%	$2K-95.8%	$49K-53.4%	$105K+1001.0%	$10K	$0
Inventory	N/A	$0-100.0%	$73K-35.6%	$113K+259.9%	$31K-37.4%	$50K
Accounts Receivable	N/A	$0-100.0%	$4K	$0	$0-100.0%	$82
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.2M+46.8%	$2.2M+41.1%	$1.6M+89.1%	$827K+219.9%	$259K	$0
Current Liabilities	$3.2M+46.8%	$2.2M+41.1%	$1.6M+89.1%	$827K+272.3%	$222K	$0
Long-Term Debt	$2.1M	N/A	$951K	N/A	N/A	N/A
Total Equity	-$3.2M-46.8%	-$2.2M-55.2%	-$1.4M-137.8%	-$595K-173.6%	-$218K-532.0%	$50K
Retained Earnings	-$8.2M-18.7%	-$6.9M-186.4%	-$2.4M-187.9%	-$841K-179.3%	-$301K	$0

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$70K+338.9%	$16K+10.0%	$15K-45.4%	$27K+9290.9%	$285-97.2%	$10K-76.9%	$44K-77.6%	$196K
Current Assets	$70K+338.9%	$16K+10.0%	$15K-45.4%	$27K+9290.9%	$285-97.2%	$10K-76.9%	$44K-77.6%	$196K
Cash & Equivalents	$9K	$0-100.0%	$998-46.4%	$2K+553.7%	$285-86.3%	$2K-92.2%	$27K-64.3%	$75K
Inventory	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$73K
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$3K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$4.2M+28.2%	$3.2M+11.5%	$2.9M+13.0%	$2.6M+9.2%	$2.4M+6.7%	$2.2M+3.1%	$2.1M+1.0%	$2.1M
Current Liabilities	$4.2M+28.2%	$3.2M+11.5%	$2.9M+13.0%	$2.6M+9.2%	$2.4M+6.7%	$2.2M+3.1%	$2.1M+138.3%	$898K
Long-Term Debt	$2.4M+18.5%	$2.1M+4.5%	$2.0M+2.6%	$1.9M+5.5%	$1.8M	N/A	N/A	$1.2M
Total Equity	-$4.1M-26.7%	-$3.2M-11.5%	-$2.9M-13.6%	-$2.5M-8.0%	-$2.4M-7.2%	-$2.2M-4.7%	-$2.1M-9.0%	-$1.9M
Retained Earnings	-$9.3M-13.0%	-$8.2M-6.4%	-$7.7M-5.2%	-$7.4M-2.9%	-$7.1M-3.0%	-$6.9M-4.8%	-$6.6M-117.1%	-$3.0M

CBDW Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	N/A	N/A	N/A	-$610K	N/A	-$95K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0+100.0%	-$87K	$0	$0	$0
Financing Cash Flow	N/A	N/A	N/A	$706K	N/A	$95K
Dividends Paid	$0	$0	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	N/A	N/A	-$73K+39.0%	-$119K	N/A	N/A	N/A	-$182K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0	$0	$0	$0	$0	$0	$0
Financing Cash Flow	N/A	N/A	$72K-40.5%	$121K	N/A	N/A	$215K-10.5%	$241K
Dividends Paid	N/A	N/A	N/A	N/A	$0	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CBDW Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	-1.6%-39.6pp	37.9%+29.5pp	8.5%-27.8pp	36.3%+12.7pp	23.7%
Operating Margin	N/A	N/A	N/A	-3872.9%	N/A	N/A
Net Margin	N/A	N/A	N/A	-3872.9%	N/A	-335.4%
Return on Equity	N/A	N/A	N/A	N/A	N/A	-452.3%
Return on Assets	N/A	N/A	N/A	-233.0%	N/A	-452.3%
Current Ratio	0.010.0	0.00-0.1	0.09-0.2	0.28	N/A	N/A
Debt-to-Equity	-0.64+0.4	-1.00-0.3	-0.67+0.7	-1.39-0.2	-1.19-1.2	0.00
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-173.3%
Current Ratio	0.02+0.0	0.010.0	0.010.0	0.01+0.0	0.000.0	0.00-0.0	0.02-0.2	0.22
Debt-to-Equity	-0.60+0.0	-0.64+0.0	-0.68+0.1	-0.75+0.0	-0.77+0.2	-1.00+0.0	-1.02-0.4	-0.63
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$3.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Medx Hldgs Inc MEDH

$898K

Eco-Growth Strategies Inc ECGS

$5.4M

Vpr Brands Lp VPRB

$2.8M

Green Leaf Innovations Inc GRLF

$233K

Hempacco Co Inc HPCO

$948K

Frequently Asked Questions

What is 1606 Corp's annual revenue?

1606 Corp (CBDW) reported $0 in total revenue for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is 1606 Corp's revenue growing?

1606 Corp (CBDW) revenue declined by 100% year-over-year, from $7K to $0 in fiscal year 2025.

How much debt does 1606 Corp have?

As of fiscal year 2025, 1606 Corp (CBDW) had $0 in cash and equivalents against $2.1M in long-term debt.

What are 1606 Corp's total assets?

1606 Corp (CBDW) had $16K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does 1606 Corp have outstanding?

1606 Corp (CBDW) had 472M shares outstanding as of fiscal year 2025.

What is 1606 Corp's current ratio?

1606 Corp (CBDW) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is 1606 Corp's debt-to-equity ratio?

1606 Corp (CBDW) had a debt-to-equity ratio of -0.64 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is 1606 Corp's debt-to-equity ratio negative or unusual?

1606 Corp (CBDW) has negative shareholder equity of -$3.2M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is 1606 Corp?

1606 Corp (CBDW) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.